Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002) - Drug Trials For Money - Paid Clinical Trials

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002)

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002)
Conditions:   Triple-negative Breast Cancer;   Non-squamous Non-small-cell Lung Cancer;   NSCLC;   Estrogen-receptor-positive Breast Cancer;   Progesterone-receptor-positive Breast Cancer;   Estrogen-receptor-negative Breast Cancer;   ER-negative Breast Cancer;   Progesterone-receptor Negative Breast Cancer;   PR-negative Breast Cancer;   HER2-negative Breast Cancer;   ER-positive Breast Cancer;   PR-positive Breast Cancer;   Platinum-resistant Ovarian Cancer;   Gastric Cancer;   Pancreatic Cancer
Intervention:   Drug: Zilovertamab vedotin
Sponsor:   VelosBio Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 22, 2021 / by / in
Comments